Australian Clinical Labs Statistics

Total Valuation

ASX:ACL has a market cap or net worth of AUD 586.54 million. The enterprise value is 880.68 million.

Market Cap	586.54M
Enterprise Value	880.68M

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	Mar 27, 2025

Share Statistics

ASX:ACL has 197.49 million shares outstanding. The number of shares has decreased by -0.78% in one year.

Current Share Class	n/a
Shares Outstanding	197.49M
Shares Change (YoY)	-0.78%
Shares Change (QoQ)	+2.12%
Owned by Insiders (%)	1.83%
Owned by Institutions (%)	61.80%
Float	173.89M

Valuation Ratios

The trailing PE ratio is 19.34 and the forward PE ratio is 15.16. ASX:ACL's PEG ratio is 0.98.

PE Ratio	19.34
Forward PE	15.16
PS Ratio	0.81
PB Ratio	3.51
P/TBV Ratio	150.70
P/FCF Ratio	3.66
P/OCF Ratio	n/a
PEG Ratio	0.98

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.43, with an EV/FCF ratio of 5.49.

EV / Earnings	28.71
EV / Sales	1.21
EV / EBITDA	4.43
EV / EBIT	13.25
EV / FCF	5.49

Financial Position

The company has a current ratio of 0.59, with a Debt / Equity ratio of 1.86.

Current Ratio	0.59
Quick Ratio	0.45
Debt / Equity	1.86
Debt / EBITDA	1.58
Debt / FCF	1.96
Interest Coverage	3.61

Financial Efficiency

Return on equity (ROE) is 18.56% and return on invested capital (ROIC) is 8.51%.

Return on Equity (ROE)	18.56%
Return on Assets (ROA)	7.11%
Return on Invested Capital (ROIC)	8.51%
Return on Capital Employed (ROCE)	17.62%
Revenue Per Employee	148,627
Profits Per Employee	6,259
Employee Count	4,900
Asset Turnover	1.25
Inventory Turnover	27.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.19% in the last 52 weeks. The beta is 1.13, so ASX:ACL's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+9.19%
50-Day Moving Average	3.37
200-Day Moving Average	3.23
Relative Strength Index (RSI)	32.01
Average Volume (20 Days)	1,395,813

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ACL had revenue of AUD 728.27 million and earned 30.67 million in profits. Earnings per share was 0.15.

Revenue	728.27M
Gross Profit	265.75M
Operating Income	66.44M
Pretax Income	46.31M
Net Income	30.67M
EBITDA	79.99M
EBIT	66.44M
Earnings Per Share (EPS)	0.15

Full Income Statement

Balance Sheet

The company has 21.57 million in cash and 315.32 million in debt, giving a net cash position of -293.75 million or -1.49 per share.

Cash & Cash Equivalents	21.57M
Total Debt	315.32M
Net Cash	-293.75M
Net Cash Per Share	-1.49
Equity (Book Value)	169.11M
Book Value Per Share	0.85
Working Capital	-85.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 167.16 million and capital expenditures -6.68 million, giving a free cash flow of 160.47 million.

Operating Cash Flow	167.16M
Capital Expenditures	-6.68M
Free Cash Flow	160.47M
FCF Per Share	0.81

Full Cash Flow Statement

Margins

Gross margin is 36.49%, with operating and profit margins of 9.12% and 4.21%.

Gross Margin	36.49%
Operating Margin	9.12%
Pretax Margin	6.36%
Profit Margin	4.21%
EBITDA Margin	10.98%
EBIT Margin	9.12%
FCF Margin	22.03%

Dividends & Yields

This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 4.04%.

Dividend Per Share	0.12
Dividend Yield	4.04%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	n/a
Payout Ratio	77.78%
Buyback Yield	0.78%
Shareholder Yield	4.82%
Earnings Yield	5.23%
FCF Yield	27.36%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:ACL has an Altman Z-Score of 2.65. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.65
Piotroski F-Score	n/a